Kleenex holds 62 percent of the US facial tissue market in Q1 2026, according to Nielsen's latest tissue market report — and that number is more remarkable than it sounds, because the last decade has been a full-scale assault. Puffs, Scott Paper, and a wave of private-label generics have thrown lower prices, rival softness claims, and viral social media campaigns at Kimberly-Clark simultaneously. The crown didn't hold by accident. It held because Kleenex treated every competitive threat as a material science problem first and a marketing problem second. Last lecture, we established that aesthetic innovation — colors, sizes, seasonal packs — was really demographic expansion in disguise. The Paper Wars take that logic further: when rivals attack your market, product engineering is your sharpest weapon. The original 1924 Kleenex was thick crepe paper, thinned and softened over decades specifically for facial use — a fact that reveals how much of Kleenex's competitive edge lives in material iteration, not just branding. Puffs, owned by Procter and Gamble, pushed hard into the premium softness tier, forcing Kimberly-Clark's hand. On January 15, 2026, Kimberly-Clark responded directly: Kleenex Ultra Soft launched with 20 percent more softness, a spec improvement timed precisely to counter Puffs' premium push. This competitive tension highlights the importance of product innovation, as Kleenex's advancements in absorbency and softness were pivotal in maintaining its market position. The threats weren't only from legacy rivals. Kleenex's response to a viral TikTok challenge in December 2025, which briefly cost them 2 percent market share, demonstrated their agility in adapting to new market dynamics. Kleenex countered on multiple fronts: a sustainability initiative in November 2025 introduced 30 percent recycled content to neutralize eco-focused competitors; a February 2026 biotech acquisition secured antiviral tissue technology to defend against health-focused challengers; and in March 2026, Kleenex patented a smart tissue with embedded moisture sensors designed to integrate with allergy apps. That last move matters, Nick, because it signals where the Paper Wars are heading — away from pure softness metrics and toward connected health products. Maintaining market dominance in facial tissue isn't a single-front battle. It requires constant innovation in softness and strength to fend off Puffs and Scott, aggressive IP filing to stay ahead of generics, and now digital and biotech plays to own the next product category before rivals define it. Dominance, as Kleenex keeps proving, is not a destination. It's a discipline you recommit to every quarter.